TRANSFOG
TRANSlational and Functional Onco-Genomics
Sixth_Framework
Skip Navigation Links Search
Partner 1: LINC
Partner name: Groupement Européen d'Intérêt Economique - Liaison Network for Cancer
Short name: LINC
Country. Belgium
Role: CO - IP coordinator

The "Groupement Européen d'Intérêt Economique - Liaison Network for Cancer" (GEIE-LINC) arose from an initiative of the Organisation of the European Cancer Institutes (OECI) aiming at strengthening European competitiveness in cancer research and contributing to creating a critical mass of research and technological resources in favour of the fight against cancer. In 2000, OECI established LINC in Brussels, a tangible as outcome of a strategic meeting that examined moves "Toward a European Space for Oncology".

LINC acts as the executive arm of OECI. Its mission, which has been so far to collect and diffuse information and to facilitate interactions between its members in cancer training, research, treatment and care, and rehabilitation and related medical disciplines, will be extended to provide management, logistics and support services to its members in the general context of joint research and integration programmes. Key issues of cancer research are taken up by LINC and assessed for further collaboration between its members and for funding opportunities with the appropriate sources. LINC intends to provide its members with an operational instrument for dealing with European initiatives such as the ERA and the 6th Framework Programmes.

LINC bridges the gap between the EU Institutions and the European Comprehensive Cancer Centres community through actions such as:

Establishing and monitoring interfaces between the national research programmes and funding sources, with a view of focusing financial and scientific resources towards key objectives;Initiating and preparing proposals and requests for funding, entering agreements on behalf of its members and taking up the role of project coordinator where appropriate;Representing as required its member's interests in European and international Institutions, virtually acting as a "European Comprehensive Cancer Centre";Collecting, analysing and diffusing information, scientists and scientific and economic experiences.
LIST OF GEIE-LINC MEMBERS
>
#
Institution
Location
Country
1
Centre de recherche Public pour la Santé Luxembourg LU
2
Centre Léon Bérard Lyon FR
3
Centro di Riferimento Oncologico Aviano IT
4
Centro Régional de Oncologia de Coimbra do Instituto Portuguese de Oncologia Francisco Gentil Coimbra PT
5
Deutsches Krebsforschungzentrum Heidelberg DE
6
Dienst Gezwelziekten U.Z. Leuven BE
7
Fundación Instituto Valenciano de Oncologia Valencia ES
8
Institut Bergonié Bordeaux FR
9
Institut Gustave Roussy Paris FR
10
Institut Jules Bordet Brussels BE
11
Institute Català d'Oncologia Hospitalet ES
12
Instituto Portugues de Oncologia Centro do Porto Porto PT
13
Instituto Portugues de Oncologia Francisco Gentil Lisboa PT
14
Israel Cancer Association Givatayim IS
15
IST Istituto Nazionale per la Ricerca sul Cancro Genoa IT
16
Istitut Curie Paris. FR
17
Istituto Europeo di Oncologia Milan
18
Istituto Nazionale per lo Studio e la Cura dei Tumori Milan IT
19
Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione "G. Pascale" Naples IT
20
Istituto Regina Elena per lo Studio e la Cura dei Tumori Rome IT
21
Istituto Superiore di Oncologia Italy IT
22
Netherlands Cancer Institute Amsterdam NL
23
OCA Oncology Center Antwerp BE
24
Oncologic Center AZ-VUB Brussels BE
25
Ospedale Oncologico Bari IT
26 Radiumhemmet the Karolinska Hospital and Institute Stockholm SW
PERSONNEL
Personnel
Title
Competence
Sex
Guy Storme Prof Chairman of the LINC and Director of the AZ-VUB Cancer Center -Brussels Belgium
M
Thomas Tursz Prof Board Member of the Linc and General Director of the Institute Gustav Roussy Paris France
M
Natale Cascinelli Prof Secretary of the LINC and Director of the Istituto Nazionale Tumori of Milan Italy
M
Ulrik Ringborg Prof Board Member of the LINC and Director of the Karolinska Institute Stockholm Sweden
M
Vitir Veloso Prof Treasurer of the LINC
M
Claudio Lombardo Dr. Co-opted to the LINC board and Scientific Attaché to the Italian Embassy in Brussels, Luxembourg and NATO.
M
REFERENCES:
Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients. Griscelli et al., Gene Ther 2003 Mar;10(5):386-95Screening of N-ras Codon 61 Mutations in Paired Primary and Metastatic Cutaneous Melanomas: Mutations Occur Early and Persist throughout Tumor Progression. Omholt et al., J. Clin Cancer Res. 2002 Nov;8(11):3468-74.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. Veronesi et al., N Engl J Med. 2002 Oct 17;347(16):1227-32. Low Incidence of Colonization and No Cases of Disseminated Mycobacterium avium Complex Infection (DMAC) in Brazilian AIDS Patients in the HAART Era. Gadelha et al., Braz J Infect Dis 2002 Oct;6(5):252-8 NF-kappaB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase. De Ridder et al., Br J Cancer. 2003 Jan 13;88(1):120-4.
UPCOMING EVENT
OECI week

OECI Week (WG workshops; Scientific Conference and General Assembly) – Budapest, 16 to 18 June 2010.
read more..
Develped and maintained by MEDINFO - DIST Updated : 27 April 2010
Comments on the web Comments on the contents